PT100896A - Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's - Google Patents

Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's

Info

Publication number
PT100896A
PT100896A PT100896A PT10089692A PT100896A PT 100896 A PT100896 A PT 100896A PT 100896 A PT100896 A PT 100896A PT 10089692 A PT10089692 A PT 10089692A PT 100896 A PT100896 A PT 100896A
Authority
PT
Portugal
Prior art keywords
interleuquin
dsrna
neutralization
pharmaceutical composition
pharmaceutical
Prior art date
Application number
PT100896A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of PT100896A publication Critical patent/PT100896A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT100896A 1991-09-26 1992-09-24 Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's PT100896A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76636391A 1991-09-26 1991-09-26

Publications (1)

Publication Number Publication Date
PT100896A true PT100896A (pt) 1993-10-29

Family

ID=25076210

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100896A PT100896A (pt) 1991-09-26 1992-09-24 Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's

Country Status (8)

Country Link
EP (1) EP0654998A1 (pt)
JP (1) JP2002514999A (pt)
AU (1) AU2554792A (pt)
CA (1) CA2120027A1 (pt)
MX (1) MX9205366A (pt)
PT (1) PT100896A (pt)
WO (1) WO1993005788A1 (pt)
ZA (1) ZA927308B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
CN108445241B (zh) * 2010-06-20 2021-11-02 佐拉生物科学公司 用于鉴定高风险冠状动脉疾病患者的脂质组学标志

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
EP0495831B1 (en) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction

Also Published As

Publication number Publication date
EP0654998A1 (en) 1995-05-31
WO1993005788A1 (en) 1993-04-01
CA2120027A1 (en) 1993-04-01
EP0654998A4 (en) 1995-01-11
JP2002514999A (ja) 2002-05-21
AU2554792A (en) 1993-04-27
MX9205366A (es) 1993-05-01
ZA927308B (en) 1993-03-29

Similar Documents

Publication Publication Date Title
DK0585252T3 (da) Farmaceutiske formuleringer
DK481989A (da) Farmaceutiske formuleringer
DK0515312T3 (da) Farmaceutisk præparat
FI922958L (fi) Farmaceutisk sammansaettning
FI981777L (fi) Farmaseuttinen ainekoostumus
FI922364A7 (fi) Farmaseuttiset koostumukset
FI901102A7 (fi) Farmaseuttiset koostumukset
FI925661L (fi) Injicerbar farmaceutisk komposition
NO923127L (no) Farmasoeytisk kombinasjonsformulering
BG91785A (bg) Лекарствена форма
FI903759A7 (fi) Oraalisesti annettava N-asetyyli-kysteiiniä sisältävä farmaseuttinen koostumus
FI893643A7 (fi) Farmaseuttisia koostumuksia
MX9200622A (es) Composicion farmaceutica
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
DE4294862T1 (de) Pharmazeutische Komposition
MX9200146A (es) Composiciones farmaceuticas deglutibles
UA26064A1 (uk) Фармацевтичhа композиція
PT100896A (pt) Composicao farmaceutica para a neutralizacao da interleuquina-1(il-1) utilizando dsrna's
DK0511991T3 (da) Farmaceutisk formulering
BR9006025A (pt) Preparacao farmaceutica
FI923869L (fi) Farmaceutiska aemnen
ITMI912766A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
BR7102348U (pt) Pirulito para aplicacao medicinal

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930526

FC3A Refusal

Effective date: 19990503